查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1947981

單細胞RNA純化試劑盒市場按應用、最終用戶、產品類型、檢體來源和試劑盒規格分類，全球預測，2026-2032年

Single Cell RNA Purification Kit Market by Application, End User, Product Type, Sample Source, Kit Format - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，單細胞 RNA 純化試劑盒市場價值將達到 1.8659 億美元，到 2026 年將成長至 2.1284 億美元，到 2032 年將達到 3.9953 億美元，複合年成長率為 11.49%。

關鍵市場統計數據
基準年 2025 1.8659億美元
預計年份：2026年 2.1284億美元
預測年份 2032 3.9953億美元
複合年成長率 (%) 11.49%

本書以清晰易懂的方式介紹了單細胞RNA分離技術，並闡述了其性能的可靠性為何決定研究的最終結果。

單細胞RNA純化技術已成為現代分子生物學和轉化研究的基礎平台。隨著實驗通量的提升和單細胞技術從專業研究團隊向更廣泛的實驗室推廣，純化試劑盒的性能、可重複性和易用性日益成為決定實驗成敗的關鍵因素。本文重點介紹使純化試劑盒從普通實用工具昇華為策略資產的技術因素，並著重指出供應商、用戶和服務供應商的機會所在。

自動化、化學創新和臨床準備如何將單細胞RNA純化重塑為一個整合的、高性能的工作流程

隨著儀器、化學和計算工作流程的進步，單細胞RNA純化技術領域正經歷變革性的轉變。自動化和高通量處理的進步，使得人們對試劑盒形式的期望更高，希望其能夠實現批次間的一致性，並與機器人液體處理平台無縫整合。同時，磁珠化學和色譜柱結構的創新，使得從傳統上難以純化的樣本來源（例如冷凍組織和低起始量血液組分）中也能進行純化，從而提高了RNA回收率和下游數據品質。

評估2025年美國關稅對套件採購中供應鏈彈性規劃與策略採購選擇的影響

2025年美國貿易政策趨勢為生命科學試劑產業的採購、供應鏈規劃和成本管理帶來了新的考量。關稅及相關貿易措施影響了供應商的籌資策略，迫使製造商和經銷商重新評估生產基地、庫存管理政策以及進口組件的合約條款。對於單細胞RNA純化試劑盒的採購商而言，這些變化使得他們更加重視供應商在原料來源、關稅風險以及確保供應連續性的緊急時應對計畫的透明度。

綜合細分分析揭示了應用需求、最終用戶畫像、產品類型、樣品來源和試劑盒形式如何共同決定採購優先順序。

細分市場分析能夠幫助我們更觀點了解單細胞RNA純化的需求促進因素和產品需求。依應用領域分類，需求分佈如下：癌症研究：生物標記發現和腫瘤微環境分析等子領域需要能夠保留脆弱轉錄本的試劑盒。細胞圖譜研究：廣泛覆蓋和跨多種組織類型的可重複性至關重要。藥物發現，包括標靶識別和毒性測試，需要高通量且經濟高效的純化方法。基因表現分析分為mRNA定序流程和總RNA定序工作流程。 mRNA定序工作流程著重於捕捉多聚腺苷酸化轉錄本，而總RNA定序工作流程則需要與核醣體RNA去除具有高度相容性。

區域研發投資趨勢、法規差異和製造地將如何影響純化試劑盒的全球應用和部署

區域趨勢持續影響著單細胞RNA純化試劑盒的市場應用路徑和供應商策略。在美洲，強大的轉化研究生態系統和成熟的生物製藥總部推動了對支援高通量藥物發現和臨床檢測開發的解決方案的需求，迫使區域製造商和經銷商提供快速響應的技術支援和及時的物流服務。政策和採購行為的轉變促使研究人員和商業機構優先考慮與那些提供檢驗的工作流程和本地化庫存緩衝的供應商建立合作關係。

頂級供應商為何引領純化試劑盒市場：結合先進的化學技術、生產規模和全面的技術支持

供應商之間的競爭日益取決於其能否將嚴謹的化學研發、可擴展的生產製造和強大的技術支援相結合。業界領導企業正投資組成多學科研發團隊，以改進微珠化學和色譜柱材料，並檢驗於包括冷凍組織和低豐度血液組分在內的各種樣本類型的通訊協定。此外，他們還與平台供應商合作，確保與下游單細胞工作流程的兼容性，從而增強對尋求整合解決方案的終端用戶的價值提案。

為供應商和買家提供切實可行的、優先排序的建議，以增強產品穩健性、供應鏈彈性和下游工作流程整合。

產業領導者和實驗室採購人員應採取一系列切實可行的策略，以掌握當前機會並降低新興風險。供應商應優先考慮並投資驗證產品在不同樣本類型（包括周邊血單核細胞、全血、貼壁和懸浮細胞培養以及新鮮和冷凍組織）中的穩健性。同時，開發可與現有實驗流程整合的自動化最佳化磁珠配方和基於檢驗的分離方案，將有助於擴大目標終端用戶群。

我們採用透明且可複製的調查方法，結合相關人員訪談、實際技術評估和供應鏈評估，為我們的策略結論提供支援。

本研究採用定性和定量相結合的三角測量方法，旨在提供可操作且可重複的研究結果。主要資訊來源包括對學術機構、生物製藥公司、臨床診斷檢查室和受託研究機構(CRO) 的實驗室主任、採購人員以及研發 (R&D) 科學家進行的結構化訪談。此外，還對技術通訊協定進行了審查，對試劑盒的化學成分和規格進行了實驗室間的比較評估，並實地走訪了生產和配銷中心，以評估供應鏈實踐和品質系統。

簡潔扼要的結論強調了創新、供應商可靠性和籌資策略之間的相互作用如何影響其採納。

單細胞RNA純化領域處於快速發展的科學與實際實驗室限制的交會點。隨著單細胞分析技術的不斷成熟，純化試劑盒的相對優勢將越來越取決於其對不同樣本輸入的適應性、與自動化系統的兼容性，以及供應商在不同操作環境下保證可重複性能的能力。因此，策略差異化將源自於化學創新、檢驗的端到端工作流程以及穩健的生產和分銷實踐的結合。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：單細胞RNA純化試劑盒市場（依應用領域分類）

  • 癌症研究
    • 生物標記發現
    • 腫瘤微環境分析
  • 細胞圖譜
  • 藥物發現
    • 目標識別
    • 毒理學研究
  • 基因表現分析
    • mRNA定序
    • 總RNA定序

9. 依最終用戶分類的單細胞RNA純化試劑盒市場

  • 學術研究
    • 政府機構
    • 大學研究所
  • 生物製藥公司
    • 大型製藥企業
    • 中小型製藥公司
  • 臨床診斷檢查室
    • 分子診斷實驗室
    • 病理檢查室
  • CRO（受託研究機構）
    • 臨床研究
    • 臨床前研究

第10章：單細胞RNA純化試劑盒市場（依產品類型分類）

  • 基於列
    • 旋轉柱
    • 真空柱
  • 以微珠為基礎的
    • 聚苯乙烯珠
    • 二氧化矽包覆珠

第11章：依檢體來源分類的單細胞RNA純化試劑盒市場

  • 血
    • 周邊血單核細胞
    • 全血
  • 細胞培養
    • 貼壁細胞
    • 懸浮細胞
  • 組織
    • 新鮮紙巾
    • 冷凍組織

第12章：單細胞RNA純化試劑盒市場（依試劑盒規格分類）

  • 散裝
  • 免洗套裝

第13章：單細胞RNA純化試劑盒市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 單細胞RNA純化試劑盒市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 單細胞RNA純化試劑盒市場（依國家分類）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

16. 美國：單細胞RNA純化試劑盒市場

17. 中國單細胞RNA純化試劑盒市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • 10x Genomics, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company（BD）
  • Bio-Rad Laboratories, Inc.
  • Cytena GmbH
  • Dolomite Bio
  • Fluxion Biosciences, Inc.
  • Illumina, Inc.
  • MGI Tech Co. Ltd.
  • Miltenyi Biotec BV & Co. KG
  • Mission Bio, Inc.
  • NanoString Technologies, Inc.
  • New England Biolabs, Inc.
  • Parse Biosciences, Inc.
  • QIAGEN NV
  • Singleron Biotechnologies GmbH
  • Sphere Fluidics Limited
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-4F7A6D4FB6C0

The Single Cell RNA Purification Kit Market was valued at USD 186.59 million in 2025 and is projected to grow to USD 212.84 million in 2026, with a CAGR of 11.49%, reaching USD 399.53 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 186.59 million
Estimated Year [2026] USD 212.84 million
Forecast Year [2032] USD 399.53 million
CAGR (%) 11.49%

A clear and compelling introduction to single-cell RNA purification technologies and why performance fidelity now determines research outcomes

Single-cell RNA purification has become a foundational enabling technology for contemporary molecular biology and translational research. As experimental throughput scales and single-cell methods migrate from specialist groups to broader laboratory adoption, the performance, reproducibility, and ease of integration of purification kits are increasingly determinative of experimental success. This introduction frames the opportunity set for suppliers, users, and service providers by clarifying the technical drivers that elevate a purification kit from utility to strategic asset.

Across both discovery and applied domains, researchers prioritize sample integrity, RNA yield, and compatibility with downstream workflows such as mRNA sequencing and total RNA sequencing. The expanding toolkit of single-cell analytics, including droplet-based platforms and microfluidic systems, places new demands on purification chemistries and formats. Consequently, stakeholders must evaluate kits not only by immediate performance metrics but also by adaptability to diverse sample sources, throughput requirements, and regulatory constraints, which together define long-term utility and procurement strategy.

How automation, chemistry innovation, and clinical-readiness are reshaping single-cell RNA purification into integrated high-performance workflows

The landscape of single-cell RNA purification is undergoing transformative shifts driven by converging advances in instrumentation, chemistry, and computational workflows. Automation and high-throughput processing have elevated expectations around kit formats that support batch consistency and seamless integration with robotic liquid-handling platforms. In parallel, innovations in magnetic bead chemistries and column architectures are enabling purifications from increasingly challenging sample sources such as frozen tissue and low-input blood fractions, improving both recovery and downstream data quality.

Another inflection is the blurring of boundaries between discovery and clinical contexts. As workflows mature and standardization improves, purification kits once confined to academic research are being evaluated by clinical diagnostics laboratories for reproducibility and regulatory readiness. This has prompted suppliers to invest in validated protocols, improved documentation, and formats that accommodate single-use clinical workflows as well as bulk packs for high-throughput labs. Additionally, the rise of integrated solutions-where kits are co-optimized with library-prep and sequencing chemistries-has created new value propositions centered on end-to-end performance rather than isolated component metrics. These shifts are accelerating adoption among a wider set of end users while simultaneously raising the bar for product differentiation and supplier reliability.

Assessing how 2025 United States tariff actions are prompting supply-chain resilience planning and strategic sourcing choices for kit procurement

Trade policy developments in the United States in 2025 have introduced new considerations for procurement, supply-chain planning, and cost management across the life-science reagent landscape. Tariffs and related trade measures have influenced supplier sourcing strategies, prompting manufacturers and distributors to reassess production footprints, inventory policies, and contractual terms for imported components. For purchasers of single-cell RNA purification kits, these dynamics have translated into greater emphasis on supplier transparency regarding origin of raw materials, tariff exposure, and contingency plans to ensure continuity of supply.

In response to tariff-driven uncertainty, many stakeholders have accelerated supplier qualification processes and expanded their supplier base to include domestic and regionally located vendors. This pivot is reflected in increased interest in product formats that reduce dependency on imported consumables, such as magnetic bead formulations that can be sourced from diversified chemical suppliers or column designs that leverage locally manufactured plastics. Consequently, procurement teams now evaluate not only technical compatibility but also supply-chain resilience, lead-time variability, and the vendor's ability to navigate customs and regulatory compliance. Strategic buyers are instituting multi-tier sourcing strategies, contractual clauses for tariff pass-through, and collaborative forecasting with preferred suppliers to mitigate the operational disruption caused by trade-policy shifts.

Integrated segmentation analysis revealing how application needs, end-user profiles, product types, sample sources, and kit formats jointly determine procurement priorities

Segmentation provides a nuanced lens for understanding demand drivers and product requirements in single-cell RNA purification. Based on application, demand is distributed across cancer research where subfields such as biomarker discovery and tumor microenvironment profiling require kits capable of preserving fragile transcripts; cell atlas initiatives where breadth and reproducibility across diverse tissue types are paramount; drug discovery domains that include target identification and toxicology studies which demand high-throughput, cost-effective formats; and gene expression analysis which bifurcates into mRNA sequencing workflows favoring polyadenylated transcript capture and total RNA sequencing workflows requiring robust ribosomal RNA depletion compatibility.

When viewed from the end-user perspective, academic research laboratories-including both government institutes and university facilities-prioritize flexibility and protocol transparency, while biopharmaceutical companies, spanning large and small pharmaceutical developers, emphasize validated lot-to-lot consistency and scale. Clinical diagnostics laboratories, from molecular diagnostics providers to pathology labs, require regulatory-grade documentation and single-use formats tailored for clinical workflows. Contract research organizations active in clinical and preclinical research demand reproducible performance across diverse sample types and the logistical efficiency to support multi-site studies. Product-type segmentation distinguishes column-based solutions-offering spin column and vacuum column variants that appeal to established bench workflows-from magnetic bead-based options, where polystyrene beads and silica-coated bead chemistries offer advantages in automation and low-input recovery. Sample-source segmentation underscores the technical diversity inherent in processing peripheral blood mononuclear cells and whole blood versus adherent or suspension cell cultures, and fresh versus frozen tissue, each of which imposes unique extraction constraints. Finally, kit-format considerations separate bulk packs, available in larger quantity configurations such as fifty packs and ten packs useful for high-throughput settings, from single-use kits that serve low-volume and standard-volume needs for regulated or contamination-sensitive environments.

Taken together, these segmentation axes illuminate where suppliers should focus product development and commercialization efforts. Application- and end-user-driven requirements create cross-cutting demands for reproducibility, documentation, and format flexibility, while product-type and sample-source distinctions inform the chemistry and engineering choices that define competitive differentiation.

How regional research investment trends, regulatory diversity, and manufacturing footprints are shaping the adoption and deployment of purification kits globally

Regional dynamics continue to shape adoption pathways and supplier strategies for single-cell RNA purification kits. In the Americas, strong translational research ecosystems and established biopharmaceutical headquarters drive demand for solutions that support high-throughput drug discovery and clinical assay development, and regional manufacturers and distributors are under pressure to provide rapid technical support and just-in-time logistics. Shifts in policy and procurement behavior have encouraged both researchers and commercial entities to prioritize supplier relationships that offer validated workflows and localized inventory buffering.

In Europe, the Middle East and Africa, heterogeneous regulatory frameworks and public research funding models create a mosaic of procurement behaviors, where clinical laboratories seek compliance-ready products and academic consortia emphasize interoperability and open protocols. This region shows pronounced interest in modular kit formats that can be adapted across diverse tissue types and sample-preparation pipelines. The Asia-Pacific region is characterized by rapid capacity growth in research infrastructure, expanding clinical diagnostics capabilities, and a growing base of domestic manufacturers; investors and purchasers here prioritize scalable kit formats, regional manufacturing partnerships, and supplier roadmaps that accommodate rapid technology transfer and local regulatory submission needs. Across all regions, cross-border logistics resilience and the ability to provide regionally tailored technical training and documentation are differentiators that accelerate adoption.

Why top-performing suppliers combine advanced chemistry, manufacturing scale, and comprehensive technical support to lead in the purification kit market

Competitive dynamics among suppliers are increasingly defined by the ability to combine rigorous chemistry development with scalable manufacturing and strong technical support. Industry leaders are investing in cross-disciplinary R&D teams to refine bead chemistries and column materials, and to validate protocols across a broader array of sample types including frozen tissue and low-abundance blood fractions. These investments are complemented by partnerships with platform providers to ensure compatibility with downstream single-cell workflows, which strengthens value propositions for end users seeking integrated solutions.

Beyond product performance, companies that excel are those that demonstrate supply-chain transparency, robust quality systems, and comprehensive training resources. Strategic moves such as expanding regional manufacturing, introducing single-use kit formats for regulated environments, and offering validated workflows for both mRNA and total RNA sequencing are shaping buyer preferences. Additionally, some suppliers are differentiating through service offerings-providing protocol validation, on-site training, or application support-which lowers the barrier to adoption for clinical and contract research organizations. Overall, success is accruing to firms that align technical excellence with logistical reliability and a clear commitment to customer enablement.

Practical and prioritized recommendations for suppliers and buyers to enhance product robustness, supply resilience, and downstream workflow integration

Industry leaders and laboratory buyers should adopt a set of actionable strategies to capitalize on current opportunities and mitigate emerging risks. Suppliers must prioritize product robustness across a spectrum of sample types, investing in validation for peripheral blood mononuclear cells, whole blood, adherent and suspension cell cultures, and both fresh and frozen tissues. Concurrently, developing magnetic bead formulations optimized for automation as well as column-based options that integrate with established bench workflows will broaden addressable end-user segments.

Procurement teams should implement supplier qualification processes that explicitly evaluate origin of components, tariff exposure, and contingency logistics to limit operational disruption. Suppliers and buyers alike will benefit from collaborative pilot projects that co-validate kits with downstream library-prep and sequencing workflows, thereby reducing adoption friction for biopharmaceutical and clinical diagnostic customers. Finally, firms should invest in modular kit formats and documentation packages that respond to the diverse needs of academic research, large and small pharmaceutical companies, clinical diagnostics laboratories, and contract research organizations, enabling both rapid adoption and long-term retention.

Transparent and reproducible research methodology combining stakeholder interviews, hands-on technical evaluations, and supply-chain assessments to underpin strategic conclusions

This research draws on a triangulation of qualitative and quantitative methods designed to deliver actionable, reproducible insights. Primary sources include structured interviews with laboratory directors, procurement managers, and R&D scientists across academic institutions, biopharmaceutical companies, clinical diagnostics laboratories, and contract research organizations. These interviews were complemented by technical protocol reviews, comparative laboratory evaluations of kit chemistries and formats, and site visits to manufacturing and distribution centers to assess supply-chain practices and quality systems.

Secondary research incorporated peer-reviewed literature on single-cell methodologies, regulatory guidance for clinical assay components, and public disclosures regarding supplier investments in manufacturing capacity and automation. Data synthesis relied on cross-validation across sources to identify consistent trends and to filter short-term noise from persistent strategic shifts. Throughout the research process, attention was given to methodological transparency, reproducibility of laboratory findings, and the contextualization of tariff and policy developments within operational procurement practices.

A concise conclusion emphasizing the interplay of technical innovation, supplier reliability, and procurement strategy in shaping adoption

The single-cell RNA purification domain sits at the intersection of rapidly evolving science and practical laboratory constraints. As technologies for single-cell analysis continue to mature, the relative advantage of purification kits will increasingly depend on their adaptability to diverse sample inputs, their compatibility with automation, and the supplier's ability to ensure reproducible performance across operational contexts. Strategic differentiation will therefore emerge from a combination of chemical innovation, validated end-to-end workflows, and resilient manufacturing and distribution practices.

For decision-makers, the imperative is to align procurement choices with long-term experimental objectives and regulatory trajectories. Suppliers that deliver documented reproducibility, comprehensive technical support, and flexible kit formats will capture the attention of both discovery-oriented and clinical customers. In the near term, organizations that emphasize supplier vetting, collaborative validation efforts, and contingency planning will be best positioned to maintain research continuity and to capitalize on the growing opportunities presented by single-cell biology.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Single Cell RNA Purification Kit Market, by Application

  • 8.1. Cancer Research
    • 8.1.1. Biomarker Discovery
    • 8.1.2. Tumor Microenvironment Profiling
  • 8.2. Cell Atlas
  • 8.3. Drug Discovery
    • 8.3.1. Target Identification
    • 8.3.2. Toxicology Studies
  • 8.4. Gene Expression Analysis
    • 8.4.1. Mrna Sequencing
    • 8.4.2. Total Rna Sequencing

9. Single Cell RNA Purification Kit Market, by End User

  • 9.1. Academic Research
    • 9.1.1. Government Institutes
    • 9.1.2. University Laboratories
  • 9.2. Biopharmaceutical Companies
    • 9.2.1. Large Pharmaceuticals
    • 9.2.2. Small Pharmaceuticals
  • 9.3. Clinical Diagnostics Laboratories
    • 9.3.1. Molecular Diagnostics Laboratories
    • 9.3.2. Pathology Laboratories
  • 9.4. Contract Research Organizations
    • 9.4.1. Clinical Research
    • 9.4.2. Preclinical Research

10. Single Cell RNA Purification Kit Market, by Product Type

  • 10.1. Column Based
    • 10.1.1. Spin Column
    • 10.1.2. Vacuum Column
  • 10.2. Magnetic Bead Based
    • 10.2.1. Polystyrene Beads
    • 10.2.2. Silica Coated Beads

11. Single Cell RNA Purification Kit Market, by Sample Source

  • 11.1. Blood
    • 11.1.1. Peripheral Blood Mononuclear Cells
    • 11.1.2. Whole Blood
  • 11.2. Cell Culture
    • 11.2.1. Adherent Cells
    • 11.2.2. Suspension Cells
  • 11.3. Tissue
    • 11.3.1. Fresh Tissue
    • 11.3.2. Frozen Tissue

12. Single Cell RNA Purification Kit Market, by Kit Format

  • 12.1. Bulk Packs
  • 12.2. Single Use Kits

13. Single Cell RNA Purification Kit Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Single Cell RNA Purification Kit Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Single Cell RNA Purification Kit Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Single Cell RNA Purification Kit Market

17. China Single Cell RNA Purification Kit Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. 10x Genomics, Inc.
  • 18.6. Agilent Technologies, Inc.
  • 18.7. Becton, Dickinson and Company (BD)
  • 18.8. Bio-Rad Laboratories, Inc.
  • 18.9. Cytena GmbH
  • 18.10. Dolomite Bio
  • 18.11. Fluxion Biosciences, Inc.
  • 18.12. Illumina, Inc.
  • 18.13. MGI Tech Co. Ltd.
  • 18.14. Miltenyi Biotec B.V. & Co. KG
  • 18.15. Mission Bio, Inc.
  • 18.16. NanoString Technologies, Inc.
  • 18.17. New England Biolabs, Inc.
  • 18.18. Parse Biosciences, Inc.
  • 18.19. QIAGEN N.V.
  • 18.20. Singleron Biotechnologies GmbH
  • 18.21. Sphere Fluidics Limited
  • 18.22. Takara Bio Inc.
  • 18.23. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SAMPLE SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY KIT FORMAT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CANCER RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CANCER RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CANCER RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CANCER RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BIOMARKER DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BIOMARKER DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TUMOR MICROENVIRONMENT PROFILING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TUMOR MICROENVIRONMENT PROFILING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TUMOR MICROENVIRONMENT PROFILING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CELL ATLAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CELL ATLAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CELL ATLAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TARGET IDENTIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TARGET IDENTIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TOXICOLOGY STUDIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TOXICOLOGY STUDIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TOXICOLOGY STUDIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY GENE EXPRESSION ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY GENE EXPRESSION ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY GENE EXPRESSION ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY GENE EXPRESSION ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY MRNA SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY MRNA SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY MRNA SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TOTAL RNA SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TOTAL RNA SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TOTAL RNA SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY GOVERNMENT INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY GOVERNMENT INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY GOVERNMENT INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY UNIVERSITY LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY UNIVERSITY LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY UNIVERSITY LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY LARGE PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY LARGE PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY LARGE PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SMALL PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SMALL PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SMALL PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY MOLECULAR DIAGNOSTICS LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY MOLECULAR DIAGNOSTICS LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY MOLECULAR DIAGNOSTICS LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY PATHOLOGY LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY PATHOLOGY LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY PATHOLOGY LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CLINICAL RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CLINICAL RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY PRECLINICAL RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY PRECLINICAL RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY PRECLINICAL RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY COLUMN BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY COLUMN BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY COLUMN BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SPIN COLUMN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SPIN COLUMN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SPIN COLUMN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY VACUUM COLUMN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY VACUUM COLUMN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY VACUUM COLUMN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY MAGNETIC BEAD BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY MAGNETIC BEAD BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY MAGNETIC BEAD BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY MAGNETIC BEAD BASED, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY POLYSTYRENE BEADS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY POLYSTYRENE BEADS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY POLYSTYRENE BEADS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SILICA COATED BEADS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SILICA COATED BEADS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SILICA COATED BEADS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BLOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BLOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY PERIPHERAL BLOOD MONONUCLEAR CELLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY PERIPHERAL BLOOD MONONUCLEAR CELLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY PERIPHERAL BLOOD MONONUCLEAR CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CELL CULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CELL CULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CELL CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY ADHERENT CELLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY ADHERENT CELLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY ADHERENT CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SUSPENSION CELLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SUSPENSION CELLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SUSPENSION CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TISSUE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TISSUE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY FRESH TISSUE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY FRESH TISSUE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY FRESH TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY FROZEN TISSUE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY FROZEN TISSUE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY FROZEN TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BULK PACKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BULK PACKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BULK PACKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SINGLE USE KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SINGLE USE KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SINGLE USE KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CANCER RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY GENE EXPRESSION ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 147. AMERICAS SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. AMERICAS SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 149. AMERICAS SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY MAGNETIC BEAD BASED, 2018-2032 (USD MILLION)
  • TABLE 150. AMERICAS SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 151. AMERICAS SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 152. AMERICAS SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 153. AMERICAS SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 154. AMERICAS SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CANCER RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY GENE EXPRESSION ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY MAGNETIC BEAD BASED, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CANCER RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY GENE EXPRESSION ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY MAGNETIC BEAD BASED, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CANCER RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY GENE EXPRESSION ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY MAGNETIC BEAD BASED, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CANCER RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY GENE EXPRESSION ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPE SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPE SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPE SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPE SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY MAGNETIC BEAD BASED, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 228. MIDDLE EAST SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CANCER RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 230. MIDDLE EAST SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY GENE EXPRESSION ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 232. MIDDLE EAST SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 234. MIDDLE EAST SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 236. MIDDLE EAST SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. MIDDLE EAST SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY MAGNETIC BEAD BASED, 2018-2032 (USD MILLION)
  • TABLE 240. MIDDLE EAST SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 242. MIDDLE EAST SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 244. MIDDLE EAST SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 245. AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 246. AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 247. AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CANCER RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 248. AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 249. AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY GENE EXPRESSION ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 250. AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 251. AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 252. AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 253. AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 254. AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 255. AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 257. AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY MAGNETIC BEAD BASED, 2018-2032 (USD MILLION)
  • TABLE 258. AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 259. AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 260. AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 261. AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 262. AFRICA SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 263. ASIA-PACIFIC SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 264. ASIA-PACIFIC SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CANCER RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY GENE EXPRESSION ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY MAGNETIC BEAD BASED, 2018-2032 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC SINGLE CELL RNA PURIFICATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 281. GLOBAL SINGLE CELL RNA PURIFI